EADV 2019

Late-Breaking News

IL-17A blocker effective in paediatric psoriasis patients

Presented By

Dr Kim Papp, Probity Medical Research, Canada

Trial

Phase 3, IXORA-PEDS

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 20:51

Rituximab beats mycophenolate mofetil in pemphigus vulgaris

Presented By

Prof. Pascal Joly, Rouen University Hospital, France

Trial

Phase 3, PEMPHIX, Ritux 3

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 19:52

Novel JAK1/2 inhibitor shows remarkable efficacy in alopecia areata

Presented By

Dr James Cassella

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 18:54

Acne highly influenced by climate, pollutants, and unhealthy diet

Presented By

Dr Delphine Kerob, Vichy Laboratories, France

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 17:56

JAK inhibition plus TCS lead to high clearance rates in AD

Presented By

Prof. Kristian Reich, Georg-August-University Göttingen, Germany

Trial

Phase 3, BREEZE-AD7

Type

Peer-reviewed article

9 December 2019 16:53

No cancer risk with long-term use of tacrolimus, a topical calcineurin inhibitor, in children with AD

Presented By

Prof. Regina Fölster-Holst, University Medical Center Schleswig-Holstein, Germany

Trial

APPLES

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 15:04

Green light for a second JAK inhibitor in AD

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Trial

Phase 3, JADE MONO-1

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 14:06

Topical ruxolitinib effective in vitiligo

Presented By

Prof. Amit Pandya, University of Texas Southwestern Medical Center, USA

Conference

EADV 2019

9 December 2019 13:08

Emerging Therapies

Small molecules: interesting novel treatment options in AD

Presented By

Prof. Tilo Biedermann, Helmholtz Center Munich, German

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 20:27

IL-1⍺ blockade: a new treatment option in AD

Presented By

Prof. Alice Gottlieb, Icahn School of Medicine at Mount Sinai, USA

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 19:51

IL-4/IL-13 blockade leads to rapid itch reduction in adolescents

Presented By

Prof. Eric Simpson, Oregon Health & Science University, USA

Trial

Phase 3, LIBERTY AD ADOL

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 18:58

How to manage conjunctivitis in AD patients treated with a biologic

Presented By

Prof. Tilo Biedermann, Helmholtz Center Munich, Germany

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 16:01

Biologics: increasingly used in paediatric dermatology

Presented By

Prof. Marieke Seyger, Radboud University Nijmegen, the Netherlands

Conference

EADV 2019

Type

Peer-reviewed article

9 December 2019 15:16

Spotlight on Psoriasis

IL-17 blocker: effective and safe in patients with comorbidities

Presented By

Dr Alice Gottlieb, Tufts University School of Medicine, USA

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 20:19

ESPRIT registry: sharp decline in mortality in patients treated with a TNF blocker

Presented By

Prof. Diamant Thaçi, University of Lübeck, Germany

Trial

ESPRIT

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 19:23

Relationship psoriasis and NAFLD: new data on the hepato-dermal axis

Presented By

Dr Daniel Nieto, La Paz Hospital, Spain

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 18:25

Novel selective IL-23 blocker equally effective in patients with metabolic syndrome

Presented By

Dr Alice Gottlieb, Tufts University School of Medicine, USA

Trial

reSURFACE 1 and 2

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 17:28

Selective IL-23 blocker crushes fumaric acids in all assessed efficacy endpoints

Presented By

Prof. Diamant Thaçi, University of Lübeck, Germany

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 16:30

No hint of teratogenicity through ixekizumab

Presented By

Prof. Alexander Egeberg, Herlev and Gentofte Hospital, Denmark

Trial

PSOLAR

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 14:32

New Insights in Photoprotection

Urticaria

Rosacea – From New Spectrum to New Therapy

The Rosacea Tracker may aid clinical decision-making

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 20:46

New guidance on rosacea therapy according to phenotype

Presented By

Prof. Martin Schaller, University of Tübingen, Germany

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 14:49

Best of the Posters

Above-the-neck melanoma more prone to metastases

Presented By

Dr Mohammed Al Abadie, Cross Hospital; Cannock Chase Hospital, United Kingdom

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 20:53

Reduced sleep quality in dermatoses influenced by itch and pain

Presented By

Dr Karolina Kaaz, Wroclaw Medical University, Poland

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 19:58

Anxiety and depression are common in families of AD infants

Presented By

Dr Vesna Grivcheva-Panovska, University Clinic in Skopje (Macedonia)

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 18:59

Certolizumab pegol efficacious for head and neck psoriasis

Presented By

Prof. Peter van de Kerkhof, Radboud University, the Netherlands

Trial

Phase 3, CIMPASI-1 and CIMPASI-2

Conference

EADV 2019

Type

Peer-reviewed article

9 October 2019 15:02